Speciality Chemicals company Balaji Amines announced Q4FY24 results: Financial Highlights: Revenue from Operations for Q4FY24 stood at Rs 423 crore, as compared to Rs 392 crore in Q3FY24. Total volumes stood at 27,984 MT for Q4FY24 as against 26,903 MT in Q3FY24. For Q4FY24, Amines volumes stood at 8,910 MT Amines Derivatives volumes stood at 9,676 MT Specialty Chemicals volumes stood at 9,398 MT EBITDA for Q4FY24 was Rs 106 crore, as compared to Rs 83 crore in Q3FY24. EBITDA margin for Q4FY24 stood at 25% as against 21% in Q3FY24. PAT for Q4FY24 was Rs 72 crore as compared to Rs 56 crore in Q3FY24. Diluted EPS for Q4FY24 stood at Rs 21.00 per equity share as against Rs 15.24 in Q3FY24. On a standalone basis, it is a zero-debt company. On the performance, D. Ram Reddy, Managing Director, commented, “In Q4 & FY24, our financial and business highlights indicate a positive trajectory, with higher volume uptake, improved EBITDA and PAT margins driven by stabilised input costs(on both raw materials and utilities fronts) and a settling industry scenario. The rebound in domestic demand, coupled with encouraging international market trends, is contributing to this momentum and enhancing our margins. Recent developments include the successful commencement of n-Butylamines production at Unit-IV, boasting an annual installed capacity of 15,000 MT. Furthermore, Unit-I and Unit-III have received BIS Certification for 'Morpholine,' enhancing our product quality standards. Both Methylamine and Dimethyl Ether projects are progressing well, showcasing our commitment to operational excellence. Looking ahead, we maintain a positive outlook for long-term opportunities, anticipating growth and increased prospects in the fiscal year 2024- 25. Our focus on inherent strengths and competencies positions us as a leading force in Amines and Specialty Chemicals, guiding us through market complexities towards greater excellence.” Result PDF